Interrupter Advanced Cream have been physician-tested in GLP-1 users, with results showing: Visible reversal of laxity in as little as 4 weeks Full improvements at 12 weeks Enhanced collagen reinforcement Reduced glycation Improved hydration, smoothness, and radiance When paired with in-office procedures such as ultrasound lifting, clinical studies show: Up to a 44% reduction in facial laxity Up to a 34% reduction in visible aging signs within 12 weeks Device-Based Skin Tightening For patients who prefer non-injectable improvements, treatments like Morpheus8 microneedling combined with radiofrequency energy can significantly improve firmness and collagen density with minimal downtime
I have yet to go back on GLP-1
Furthermore, WB analysis was conducted on extracts from the aortas of aging mice, showing consistent results with in vitro experiments: increased expression of p-P53 and decreased expression of total P53 after FOXO4-DRI treatment
Anyone with a personal or family history of medullary thyroid carcinoma or MEN 2 (a boxed-warning contraindication), a history of pancreatitis, or serious hypersensitivity to semaglutide
K., Chapron, C., Giudice, L
#MetabolicHealth #GLP1 #Pfizer #Metsera #Biotech #PharmaInnovation #ObesityTherapeutics (Refs: Pfizer Press Release 2025
